BioCentury
ARTICLE | Clinical News

Xarelto rivaroxaban regulatory update

October 29, 2012 7:00 AM UTC

EMA's CHMP issued a positive opinion to extend the indication for Xarelto rivaroxaban from Bayer to include treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurr...